✦ LIBER ✦

Switching from other antipsychotics to once-daily extended release quetiapine fumarate in patients with schizophrenia*

✍ Scribed by Ganesan, S.; Agambaram, V.; Randeree, F.; Eggens, I.; Huizar, K.; Meuliend, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical benefit of switching patients w

✍ Ganesan, S.; Agambaram, V.; Randeree, F.; Eggens, I.; Schmidt, M.M.; Meulien, D. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 55 KB

The long-term clinical benefit and effec

✍ Chue, P.; Malla, A.; Bouchard, R.-H.; Lessard, S.; Ganesan, S.; Stip, E.; Johnso 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 441 KB

Once-daily extended release quetiapine f

✍ D. Meulien; M. Brecher; K. Huizar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 49 KB

PMH71 The Impact of Once-Daily Extended-

✍ J.C. Locklear; P. Wahlqvist; U. Gustafsson; M. Udd; L. Fajutrao; H. Eriksson 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

P01-275 Analysis of pooled data: Once-da

✍ S. Montgomery; R. Weisler; W. Earley; M. Åstrom; A. Lazarus 📂 Article 📅 2009 🏛 Elsevier Science 🌐 French ⚖ 50 KB

Effects of once-daily extended release q

✍ Locklear, Julie C.; Svedsäter, Henrik; Datto, Catherine; Endicott, Jean 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 319 KB